Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Short Interest Update

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 24,397 shares, a drop of 46.5% from the August 31st total of 45,624 shares. Based on an average daily trading volume, of 28,177 shares, the short-interest ratio is presently 0.9 days. Approximately 0.2% of the shares of the company are short sold.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. World Investment Advisors bought a new stake in Columbia Research Enhanced Value ETF during the 4th quarter worth approximately $1,169,000. First Interstate Bank bought a new stake in Columbia Research Enhanced Value ETF during the first quarter valued at $1,321,000. Envestnet Asset Management Inc. grew its position in Columbia Research Enhanced Value ETF by 13.9% during the second quarter. Envestnet Asset Management Inc. now owns 361,667 shares of the company’s stock worth $11,371,000 after buying an additional 44,147 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new position in Columbia Research Enhanced Value ETF during the second quarter worth about $188,000. Finally, Ruggaard & Associates LLC increased its stake in Columbia Research Enhanced Value ETF by 0.6% in the 1st quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock worth $1,500,000 after acquiring an additional 322 shares during the last quarter.

Columbia Research Enhanced Value ETF Trading Up 0.0%

Shares of NYSEARCA:REVS traded up $0.01 during mid-day trading on Thursday, reaching $32.81. The company had a trading volume of 22,985 shares, compared to its average volume of 50,728. The firm has a market cap of $344.50 million, a price-to-earnings ratio of 16.41 and a beta of 0.79. The company’s 50-day moving average price is $33.66 and its 200-day moving average price is $31.80. Columbia Research Enhanced Value ETF has a one year low of $27.24 and a one year high of $34.55.

Columbia Research Enhanced Value ETF Company Profile

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.